ABL1 and acute lymphoblastic leukemia: Classic mouse models of transgenic-driven BCR-ABL ALL showed a 100% penetrance of B-ALL disease [61,62], something that does not happen in human patients, therefore not allowing one to explore the preleukemic transformation process similarly taking place.